US-based pharmaceutical contract development and manufacturing organization (CDMO) specializing in micronization and particle-size control for small-molecule APIs and excipients
US-based pharmaceutical contract development and manufacturing organization (CDMO) specializing in micronization and particle-size control for small-molecule APIs and excipients. Its services help drug developers improve dissolution and bioavailability, including for poorly soluble and highly potent compounds, from development through commercial-scale production.